Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2006 | |
| Sales | 48,058 | 49,856 | 50,319 | 51,954 | 0 |
| Gross Profit | 48,058 | 49,856 | 50,319 | 51,954 | N/A |
| Operating Expenses | 94,970 | 56,738 | 50,653 | 48,329 | 0 |
| Operating Income | -46,912 | -6,882 | -334 | 3,625 | N/A |
| Other Income | -756 | 214 | 32 | 43 | 0 |
| Pre-tax Income | -47,668 | -6,668 | -302 | 3,668 | 0 |
| Income Tax | 3 | -441 | 1,148 | 2,979 | N/A |
| Net Income Continuous | -47,671 | -6,227 | -1,450 | 689 | N/A |
| Net Income | $-47,671 | $-6,227 | $-1,450 | $689 | $N/A |
| EPS Basic Total Ops | -1.99 | -0.31 | -0.09 | 0.04 | N/A |
| EPS Basic Continuous Ops | -1.99 | -0.31 | -0.09 | 0.04 | N/A |
| EPS Diluted Total Ops | -1.99 | -0.31 | -0.09 | 0.04 | N/A |
| EPS Diluted Continuous Ops | -1.99 | -0.31 | -0.09 | 0.04 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.99 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-46,337 | $-6,200 | $1,485 | $6,137 | $N/A |